Inventor · Framingham, MA, US

Romesh R. Subramanian

66Patents
22h-index
18Co-inventors
81Inventor score

Filing activity: Sep 14, 2012 → May 19, 2025

Most-cited inventions

PatentTitleAreaCited byStatus
US11111309B2 Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4 Chemistry; Metallurgy 56 Active
US11286305B2 Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA Chemistry; Metallurgy 55 Active
US11168141B2 Muscle targeting complexes and uses thereof for treating dystrophinopathies Chemistry; Metallurgy 48 Active
US11248056B1 Muscle targeting complexes and uses thereof for treating dystrophinopathies Chemistry; Metallurgy 46 Active
US11390682B2 Methods of intravenouisly delivering anti-transferrin antibody/oligonucleotide complexes to subjects having muscular dystrophy Chemistry; Metallurgy 44 Active
US11369689B2 Muscle targeting complexes and uses thereof for treating dystrophinopathies Chemistry; Metallurgy 44 Active
US11497815B2 Muscle targeting complexes and uses thereof for treating dystrophinopathies Chemistry; Metallurgy 42 Active
US11518816B2 Methods of delivering an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 42 Active
US11638761B2 Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 39 Active
US11679161B2 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 31 Active
US11633498B2 Muscle targeting complexes and uses thereof for treating myotonic dystrophy Chemistry; Metallurgy 31 Active
US11633496B2 Muscle targeting complexes and uses thereof for treating dystrophinopathies Chemistry; Metallurgy 31 Active
US11672872B2 Anti-transferrin receptor antibody and uses thereof Chemistry; Metallurgy 31 Active
US11648318B2 Anti-transferrin receptor (TFR) antibody and uses thereof Chemistry; Metallurgy 31 Active
US11795233B2 Muscle-targeting complex comprising an anti-transferrin receptor antibody linked to an oligonucleotide Chemistry; Metallurgy 27 Active
US11759525B1 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 27 Active
US11787869B2 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness Chemistry; Metallurgy 27 Active
US11771776B2 Muscle targeting complexes and uses thereof for treating dystrophinopathies Chemistry; Metallurgy 27 Active
US11795234B2 Methods of producing muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide Chemistry; Metallurgy 27 Active
US11844843B2 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 25 Active
US11839660B2 Anti-transferrin receptor antibody and uses thereof Chemistry; Metallurgy 25 Active
US11833217B2 Muscle targeting complexes and uses thereof for treating dystrophinopathies Chemistry; Metallurgy 25 Active
US11911484B2 Muscle targeting complexes and uses thereof for treating myotonic dystrophy Chemistry; Metallurgy 22 Active
US11969475B2 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 20 Active
US11931421B2 Muscle targeting complexes and formulations for treating myotonic dystrophy Chemistry; Metallurgy 20 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.